Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1

Microbiology

Volumn 157, Issue 4, 2011, Pages 1134-1144

  Gong, Siqi ^a   Lei, Lei ^a   Chang, Xiaotong ^a   Belland, Robert ^b   Zhong, Guangming ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIAL PROTEIN; HYDRAZIDE DERIVATIVE; MESSENGER RNA; N' (3,5 DIBROMO 2 HYDROXYBENZYLIDENE) 4 NITROBENZOHYDRAZIDE; PROTEIN CT621; PROTEIN CT622; UNCLASSIFIED DRUG;

ARTICLE; CHLAMYDIA TRACHOMATIS; CYTOPLASM; GENE EXPRESSION; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TYPE III SECRETION SYSTEM;

BACTERIAL PROTEINS; CHLAMYDIA TRACHOMATIS; CYTOPLASM; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HELA CELLS; HUMANS; HYDRAZINES; SECRETORY PATHWAY; VIRULENCE FACTORS;

CHLAMYDIA TRACHOMATIS; MAMMALIA;

EID: 79953728755     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.047746-0     Document Type: Article

References (67)

1. Aiello, D., Williams, J. D., Majgier-Baranowska, H., Patel, I., Peet, N. P., Huang, J., Lory, S., Bowlin, T. L. & Moir, D. T. (2010). Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion. Antimicrob Agents Chemother 54, 1988-1999.
2. Andersen, J. N., Sathyanarayanan, S., Di Bacco, A., Chi, A., Zhang, T., Chen, A. H., Dolinski, B., Kraus, M., Roberts, B. & other authors (2010). Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors. Sci Transl Med 2, ra55.
3. Arnold, R., Brandmaier, S., Kleine, F., Tischler, P., Heinz, E., Behrens, S., Niinikoski, A., Mewes, H. W., Horn, M. & Rattei, T. (2009). Sequence-based prediction of type III secreted proteins. PLoS Pathog 5, e1000376.
4. Balsalobre, C., Silván, J. M., Berglund, S., Mizunoe, Y., Uhlin, B. E. & Wai, S. N. (2006). Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli. Mol Microbiol 59, 99-112.
5. Belland, R. J., Zhong, G., Crane, D. D., Hogan, D., Sturdevant, D., Sharma, J., Beatty, W. L. & Caldwell, H. D. (2003). Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A 100, 8478-8483.
6. Betts-Hampikian, H. & Fields, K. (2010). The chlamydial type III secretion mechanism: revealing cracks in a tough nut. Front Cell Infect Microbiol 1.
7. Chellas-Géry, B., Linton, C. N. & Fields, K. A. (2007). Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model. Cell Microbiol 9, 2417-2430.
8. Chen, C., Chen, D., Sharma, J., Cheng, W., Zhong, Y., Liu, K., Jensen, J., Shain, R., Arulanandam, B. & Zhong, G. (2006). The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect Immun 74, 4826-4840.
9. Chen, D., Chai, J., Hart, P. J. & Zhong, G. (2009). Identifying catalytic residues in CPAF, a Chlamydia-secreted protease. Arch Biochem Biophys 485, 16-23.
10. Chen, D., Lei, L., Lu, C., Flores, R., DeLisa, M. P., Roberts, T. C., Romesberg, F. E. & Zhong, G. (2010). Secretion of the chlamydial virulence factor CPAF requires the Sec-dependent pathway. Microbiology 156, 3031-3040.
11. Clifton, D. R., Fields, K. A., Grieshaber, S. S., Dooley, C. A., Fischer, E. R., Mead, D. J., Carabeo, R. A. & Hackstadt, T. (2004). A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A 101, 10166-10171.
12. Cocchiaro, J. L., Kumar, Y., Fischer, E. R., Hackstadt, T. & Valdivia, R. H. (2008). Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci U S A 105, 9379-9384.
13. den Hartog, J. E., Morré, S. A. & Land, J. A. (2006). Chlamydia trachomatis-associated tubal factor subfertility: immunogenetic aspects and serological screening. Hum Reprod Update 12, 719-730.
14. Dong, F., Su, H., Huang, Y., Zhong, Y. & Zhong, G. (2004). Cleavage of host keratin 8 by a Chlamydia-secreted protease. Infect Immun 72, 3863-3868.
15. Dong, F., Flores, R., Chen, D., Luo, J., Zhong, Y., Wu, Z. & Zhong, G. (2006). Localization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells. Infect Immun 74, 6479-6486.
16. Ellis, T. N. & Kuehn, M. J. (2010). Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 74, 81-94.
17. Fan, T., Lu, H., Hu, H., Shi, L., McClarty, G. A., Nance, D. M., Greenberg, A. H. & Zhong, G. (1998). Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 187, 487-496.
18. Fan, P., Dong, F., Huang, Y. & Zhong, G. (2002). Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors is required for major histocompatibility complex antigen expression. Infect Immun 70, 345-349.
19. Fields, K. A., Mead, D. J., Dooley, C. A. & Hackstadt, T. (2003). Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol Microbiol 48, 671-683.
20. Galka, F., Wai, S. N., Kusch, H., Engelmann, S., Hecker, M., Schmeck, B., Hippenstiel, S., Uhlin, B. E. & Steinert, M. (2008). Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles. Infect Immun 76, 1825-1836.
21. Giles, D. K., Whittimore, J. D., LaRue, R. W., Raulston, J. E. & Wyrick, P. B. (2006). Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion. Microbes Infect 8, 1579-1591.
22. Hackstadt, T., Scidmore, M. A. & Rockey, D. D. (1995). Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A 92, 4877-4881.
23. Hackstadt, T., Fischer, E. R., Scidmore, M. A., Rockey, D. D. & Heinzen, R. A. (1997). Origins and functions of the chlamydial inclusion. Trends Microbiol 5, 288-293.
24. Hackstadt, T., Scidmore-Carlson, M. A., Shaw, E. I. & Fischer, E. R. (1999). The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol 1, 119-130.
25. Harmon, D. E., Davis, A. J., Castillo, C. & Mecsas, J. (2010). Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis. Antimicrob Agents Chemother 54, 3241-3254.
26. Hobolt-Pedersen, A. S., Christiansen, G., Timmerman, E., Gevaert, K. & Birkelund, S. (2009). Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus. FEMS Immunol Med Microbiol 57, 46-58.
27. Hower, S., Wolf, K. & Fields, K. A. (2009). Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol 72, 1423-1437.
28. Huang, Z., Feng, Y., Chen, D., Wu, X., Huang, S., Wang, X., Xiao, X., Li, W., Huang, N. & Gu, L. (2008). Structural basis for activation and inhibition of the secreted chlamydia protease CPAF. Cell Host Microbe 4, 529-542.
29. Kauppi, A. M., Nordfelth, R., Uvell, H., Wolf-Watz, H. & Elofsson, M. (2003). Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol 10, 241-249.
30. Kim, J. Y., Doody, A. M., Chen, D. J., Cremona, G. H., Shuler, M. L., Putnam, D. & DeLisa, M. P. (2008). Engineered bacterial outer membrane vesicles with enhanced functionality. J Mol Biol 380, 51-66.
31. Kouokam, J. C., Wai, S. N., Fällman, M., Dobrindt, U., Hacker, J. & Uhlin, B. E. (2006). Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Infect Immun 74, 2022-2030.
32. Kuehn, M. J. & Kesty, N. C. (2005). Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 19, 2645-2655.
33. Kumar, Y. & Valdivia, R. H. (2008). Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 4, 159-169.
34. Li, Z., Chen, C., Chen, D., Wu, Y., Zhong, Y. & Zhong, G. (2008a). Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun 76, 2746-2757.
35. Li, Z., Chen, D., Zhong, Y., Wang, S. & Zhong, G. (2008b). The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun 76, 3415-3428.
36. McClarty, G. (1994). Chlamydiae and the biochemistry of intracellular parasitism. Trends Microbiol 2, 157-164.
37. Mertz, K. J., McQuillan, G. M., Levine, W. C., Candal, D. H., Bullard, J. C., Johnson, R. E., St Louis, M. E. & Black, C.M. (1998). A pilot study of the prevalence of chlamydial infection in a national household survey. Sex Transm Dis 25, 225-228.
38. Misaghi, S., Balsara, Z. R., Catic, A., Spooner, E., Ploegh, H. L. & Starnbach, M. N. (2006). Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol Microbiol 61, 142-150.
39. Mullaney, E., Brown, P. A., Smith, S. M., Botting, C. H., Yamaoka, Y. Y., Terres, A. M., Kelleher, D. P. & Windle, H. J. (2009). Proteomic and functional characterization of the outer membrane vesicles from the gastric pathogen Helicobacter pylori. Proteomics Clin Appl 3, 785-796.
40. Nordfelth, R., Kauppi, A. M., Norberg, H. A., Wolf-Watz, H. & Elofsson, M. (2005). Small-molecule inhibitors specifically targeting type III secretion. Infect Immun 73, 3104-3114.
41. Peterman, T. A., Tian, L. H., Metcalf, C. A., Satterwhite, C. L., Malotte, C. K., DeAugustine, N., Paul, S. M., Cross, H., Rietmeijer, C. A. & other authors (2006). High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 145, 564-572.
42. Pirbhai, M., Dong, F., Zhong, Y., Pan, K. Z. & Zhong, G. (2006). The secreted protease factor CPAF is responsible for degrading proapoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. J Biol Chem 281, 31495-31501.
43. Rockey, D. D., Scidmore, M. A., Bannantine, J. P. & Brown, W. J. (2002). Proteins in the chlamydial inclusion membrane. Microbes Infect 4, 333-340.
44. Rockey, D. D., Wang, J., Lei, L. & Zhong, G. (2009). Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Rev Vaccines 8, 1365-1377.
45. Samudrala, R., Heffron, F. & McDermott, J. E. (2009). Accurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systems. PLoS Pathog 5, e1000375.
46. Scidmore, M. (2008). Chlamydia weave a protective cloak spun of actin and intermediate filaments. Cell Host Microbe 4, 93-95.
47. Sharma, J., Bosnic, A. M., Piper, J. M. & Zhong, G. (2004). Human antibody responses to a Chlamydia-secreted protease factor. Infect Immun 72, 7164-7171.
48. Sharma, J., Zhong, Y., Dong, F., Piper, J. M., Wang, G. & Zhong, G. (2006). Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun 74, 1490-1499.
49. Sherman, K. J., Daling, J. R., Stergachis, A., Weiss, N. S., Foy, H. M., Wang, S. P. & Grayston, J. T. (1990). Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis 17, 115-121.
50. Slepenkin, A., de la Maza, L. M. & Peterson, E. M. (2005). Interaction between components of the type III secretion system of Chlamydiaceae. J Bacteriol 187, 473-479.
51. Slepenkin, A., Enquist, P. A., Hägglund, U., de la Maza, L. M., Elofsson, M. & Peterson, E. M. (2007). Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron. Infect Immun 75, 3478-3489.
52. Spaeth, K. E., Chen, Y. S. & Valdivia, R. H. (2009). The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex. PLoS Pathog 5, e1000579.
53. Stephens, R. S. (2003). The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 11, 44-51.
54. Su, H., McClarty, G., Dong, F., Hatch, G. M., Pan, Z. K. & Zhong, G. (2004). Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J Biol Chem 279, 9409-9416.
55. Subtil, A., Delevoye, C., Balañá, M. E., Tastevin, L., Perrinet, S. & Dautry-Varsat, A. (2005). A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol 56, 1636-1647.
56. Toye, B., Laferrière, C., Claman, P., Jessamine, P. & Peeling, R. (1993). Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis 168, 1236-1240.
57. Valdivia, R. H. (2008). Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Curr Opin Microbiol 11, 53-59.
58. Vandahl, B. B., Stensballe, A., Roepstorff, P., Christiansen, G. & Birkelund, S. (2005). Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism. Cell Microbiol 7, 825-836.
59. Wolf, K., Betts, H. J., Chellas-Géry, B., Hower, S., Linton, C. N. & Fields, K. A. (2006). Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol 61, 1543-1555.
60. Wright, H. R., Turner, A. & Taylor, H. R. (2008). Trachoma. Lancet 371, 1945-1954.
61. Xiao, Y., Zhong, Y., Su, H., Zhou, Z., Chiao, P. & Zhong, G. (2005). NF-kappa B activation is not required for Chlamydia trachomatis inhibition of host epithelial cell apoptosis. J Immunol 174, 1701-1708.
62. Zhong, G. (2009). Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol 17, 467-474.
63. Zhong, G., Reis e Sousa, C. & Germain, R. N. (1997). Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc Natl Acad Sci U S A 94, 13856-13861.
64. Zhong, G., Fan, T. & Liu, L. (1999). Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J Exp Med 189, 1931-1938.
65. Zhong, G., Liu, L., Fan, T., Fan, P. & Ji, H. (2000). Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J Exp Med 191, 1525-1534.
66. Zhong, G., Fan, P., Ji, H., Dong, F. & Huang, Y. (2001). Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193, 935-942.
67. Zhong, G., Lei, L., Gong, S., Lu, C., Qi, M. & Chen, D. (2011). Chlamydia-secreted proteins in chlamydial interactions with host cells. Current Chemical Biology 5, 29-37.